Charles River

Charles River’s areas of interest and services available

Charles River offer preferred pricing to academic researchers in the Milner Therapeutics Consortium to improve and expedite the discovery, early-stage development and safe manufacture of new therapies in the following areas:

Basic Research

  • Research Animal Models
  • Laboratory Animal Equipment
  • Research Animal Diagnostic Services
  • Genetically Engineered Models and Services
 Discovery

  • Target Discovery and Validation
  • Assay Development and Screening
  • Synthetic, Medicinal and Process Chemistry
  • In Vitro ADME
  • In Vivo Pharmacology
  • Discovery Pharmacokinetics
Safety Assessment 

  • General and Specialty Toxicology
  • Safety Pharmacology
  • Drug Metabolism and Pharmacokinetics
  • Laboratory Sciences
  • Anatomic and Clinical Pathology
 Clinical Support

  • Clinical Sample Analysis
  • Clinical Sample Kits
  • Pathology for Clinical Trials
  • Specialty Toxicology
  • Clinical-Scale Manufacturing
Manufacturing

  • Contract Manufacturing
  • Cell Line and Protein Characterization
  • Cell Banking
  • Biosafety, Impurity and Potency Testing
  • Viral Clearance Studies
  • Endotoxin Detection
  • Rapid Bioburden and Microbial Identification
  • Avian Vaccine Products and Services

Contact details:

For questions or to discuss programs and projects please contact:

  • Dr John Montana, Executive Director
  • Scientific Alliances Discovery Services
  • + 44 7939 001307

Charles River offers products, services and expertise at a preferred rate to academic scientists

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

With more than six decades of experience, our expertise in basic research models is unmatched, allowing us to provide you with the perfect model, including disease-specific and preconditioned options, for basic research and beyond. From target discovery to lead candidate selection, you can count on our expertise in oncology, CNS, metabolic, inflammation and other disease areas.

Whether you need a single study or a complete IND-enabling program for your safety assessment, we work with you on the design and execution, giving you the confidence that comes from knowing your study will be done right and on time.

Utilizing our knowledge of your drug’s path from discovery through safety assessment, our scientists can transition your drug seamlessly into the clinic. Our extensive global portfolio includes clinical sample analysis as well as any additional in vitro and in vivo nonclinical studies needed to support the continuation of your clinical trials. We are world-renowned for our developmental, reproductive and specialty toxicology expertise.

Our products and testing services for pharmaceuticals and biologics ensure safe manufacture and timely product release to help you meet the necessary global regulatory requirements to get your products to market and to the patients who need them the most.

FIND OUT MORE